AIHTA - Publications - Search - Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA) A*02:01 positive patients with unresectable or metastatic uveal melanoma

Wolf, S. (2022): Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA) A*02:01 positive patients with unresectable or metastatic uveal melanoma. Oncology Fact Sheet Nr. 79.

[thumbnail of Oncology Fact Sheet Nr.79.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
100kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WW Ophthalmology > WW 101-170 Eye
Language:English
Series Name:Oncology Fact Sheet Nr. 79
Deposited on:28 Mar 2022 12:34
Last Modified:16 May 2022 09:34

Repository Staff Only: item control page